Trimetazidine Dihydrochloride IP 35 mg  Modified Release Tablet

Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet

181.0 INR/Strip

Product Details:

  • Dosage Form Tablet
  • Pacakaging (Quantity Per Box) 10x10 tablet
  • Salt Composition Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet
  • Indication Trimetazidine Dihydrochloride IP 35mg is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
  • Ingredients Azathioprine (25 mg).
  • Physical Form Tablets
  • Dosage 35 mg
  • Click to View more
X

Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet Price And Quantity

  • 181.0 INR/Strip
  • 100 Strip

Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet Product Specifications

  • Tablet
  • 35 mg
  • 10x10 tablet
  • Azathioprine (25 mg).
  • Trimetazidine Dihydrochloride IP 35mg is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
  • Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet
  • Tablets
  • Use as directed by a healthcare professional

Product Description

Description

  • Each Film Coated Modified Release Tablet Contains: Trimetazidine Dihydrochloride IP 35 mg

Doses

  • As Directed by Physician

Indication

Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor



Mechanism of Action

Trimetazidine Dihydrochloride IP 35 mg operates by regulating cellular energy processes in the heart, particularly during ischemic episodes. By inhibiting fatty acid oxidation, it ensures sustained energy supply to the myocardium through improved glucose utilization, which helps in minimizing cellular damage during angina episodes.


Packaging and Dosage Form

This medication comes in a convenient tablet form, with each box containing 100 tablets (10 strips of 10). The modified release design ensures a controlled and steady release of the active ingredient for consistent therapeutic effect throughout the day. Always adhere to the dosing regimen prescribed by your healthcare provider.


Distribution and Availability

The product is readily available across India and can be sourced through authorized dealers, distributors, exporters, importers, and retailers. Healthcare providers, pharmacies, and medical supply chains ensure easy access for both patients and healthcare professionals.

FAQ's of Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet:


Q: How does Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet benefit patients with angina?

A: Trimetazidine Dihydrochloride IP 35 mg improves myocardial glucose utilization and inhibits fatty acid metabolism, aiding heart cells in maintaining optimal energy production during reduced blood supply and reducing the frequency of angina attacks.

Q: What is the recommended process for taking this medication?

A: This medication should be taken exactly as prescribed by your healthcare professional. The dosing schedule and duration are determined based on individual health needs, and tablets should be swallowed whole with an appropriate amount of water.

Q: When should I use Trimetazidine Dihydrochloride IP 35 mg?

A: This medication is intended for regular use, typically on a daily basis, or as specifically advised by your doctor to manage angina symptoms and improve cardiac performance over time.

Q: Where can I purchase Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablets?

A: You can obtain these tablets throughout India from registered dealers, distributors, pharmacies, and healthcare facilities. It is also available from various suppliers and wholesalers.

Q: What makes the modified release formulation beneficial?

A: The modified release formulation allows for a steady and sustained release of the active component, Trimetazidine Dihydrochloride IP, ensuring consistent therapeutic levels in the body and potentially reducing the frequency of dosing.

Q: What precautions should be taken while using this medication?

A: Always use the medication as directed by a healthcare professional and inform them about any other medications you are taking. Do not alter the dose without medical consultation.

Q: How should the tablets be stored?

A: Store the tablets in a cool, dry place away from moisture and direct sunlight, and always keep them out of reach of children.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Cardic Care Medicine' category



We accept minimum 10 boxes of all products.
Back to top